We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CNQ:TSXCanadian Natural Resources Limited Analysis

Data as of 2026-05-13 - not real-time

CA$64.27

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Canadian Natural Resources is trading just above its short‑term moving average, with a neutral RSI and a modest bullish MACD crossover, suggesting limited upside momentum in the near term. The stock’s beta is slightly negative and its recent volatility has been elevated, while trading volume shows a downward trend, indicating a potential softening of demand. Despite a solid dividend yield and a payout ratio well below fifty percent, the discounted cash‑flow model places the fair value well below the current market price, highlighting a significant overvaluation gap. Analyst consensus remains positive with a “buy” rating, yet the technical and valuation signals point to caution.
Fundamentally, the company maintains healthy operating margins, strong cash flow generation and a reasonable debt profile, supporting its dividend sustainability. Revenue growth has been modestly negative, but profitability metrics remain robust, and the return on equity is respectable for the energy sector. The high dividend yield offers income appeal, but sector‑specific risks such as commodity price swings and regulatory pressures temper enthusiasm. Overall, the stock appears overvalued on intrinsic grounds while offering dividend income, suggesting a nuanced stance across investment horizons.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • price well above intrinsic estimate
  • elevated short‑term volatility
  • declining trading volume

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • strong dividend yield and sustainable payout
  • solid cash flow and operating margins
  • neutral technical stance

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • potential commodity price recovery
  • stable dividend income
  • reasonable debt levels and ROE

Key Metrics & Analysis

Financial Health

Revenue Growth-1.20%
Profit Margin25.13%
P/E Ratio11.8
ROE22.83%
ROA5.04%
Debt/Equity44.85
P/B Ratio3.0
Op. Cash FlowCA$14.1B
Free Cash FlowCA$5.3B
Industry P/E20.9

Technical Analysis

TrendNeutral
RSI53.8
SupportCA$57.55
ResistanceCA$65.89
MA 20CA$62.36
MA 50CA$64.27
MA 200CA$50.79
MACDBullish
VolumeDecreasing
Fear & Greed Index89.5

Valuation

Fair ValueCA$24.82
Target PriceCA$70.65
Upside/Downside9.93%
GradeOvervalued
TypeValue
Dividend Yield3.89%

Risk Assessment

Beta-0.25
Volatility44.45%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.